CDC in Georgia by Center for Global Health (U.S.)
AT A GLANCE
Population: 3,717,000 (2017)
Per capita income: $10,120
Life expectancy at birth: F 78/M 69 years
Infant mortality rate: 10/1,000 live births
TOP 10 CAUSES OF DEATH
1.    lschemic heart disease
2.    Stroke
3.    Hypertensive heart disease
4.    Alzheimer’s disease
5.    Lung cancer
6.    Chronic obstructive pulmonary disease
7.    Cirrhosis
8.    Diabetes
9.    Stomach cancer
10.  Chronic kidney disease   
CDC STAFF
5  Locally Employed
Global Health Security 
In today’s globally connected world, disease threats can spread faster and 
more unpredictably than ever before. CDC’s global health security efforts in 
Georgia help improve the country’s ability to prevent, detect, and respond to 
infectious disease outbreaks before they become epidemics that could affect 
global populations. These efforts help Georgia reach the targets outlined in the 
Global Health Security Agenda (GHSA), a global partnership launched in 2014 
to help make the world safer and more secure from infectious disease threats. 
Under GHSA, Georgia is committed to strengthening real-time surveillance and 
the national laboratory system, as well as detection and prevention of zoonotic 
diseases, with the Georgia National Center for Disease Control and Public Health 
(NCDC) as a key leading institution. 
Field Epidemiology and Laboratory Training 
Program
CDC supports the country of Georgia in strengthening the capacity of its 
workforce to investigate and respond to disease outbreaks through the South 
Caucasus Field Epidemiology and Laboratory Training Program (SC/FELTP).  
SC/FELTP trains a workforce of field epidemiologists—or disease detectives—
to identify and contain outbreaks before they become epidemics. This 2-year 
competency-based program builds self-sustaining workforce capacity in 
the countries of Georgia, Azerbaijan, Armenia, and Ukraine by training local 
epidemiologists, veterinarians, and laboratory managers in field epidemiology, 
veterinary epidemiology, and laboratory quality management systems. 
Graduates often assume leadership positions within their country and over 90% 
remain employed within their respective public health agency. CDC is working 
with NCDC on the transition of the SC/FELTP to be housed as part of a Masters 
of Public Health Program at a local university.
The Centers for Disease Control and Prevention (CDC) first engaged with the country of Georgia in 1995 to assist with 
the investigation of a large-scale diphtheria outbreak. Partnering with Georgia’s National Center for Disease Control and 
Public Health and other ministries, CDC helps develop capacity to detect and respond to disease outbreaks. CDC provides 
support to strengthen laboratory, surveillance, and workforce capacity for key public health issues such as hepatitis C 
virus elimination, measles, rabies, and polio eradication.
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Laboratory Capacity Building
Since 2008, CDC has been training managers in the Georgia NCDC on laboratory 
quality management systems and project management. This unified approach to 
laboratory management capacity building includes: 
 • Strengthening management capacity through needs-assessments and 
skill-building workshops. 
 • Establishing reference laboratory capacity and functions in line with the 
International Health Regulations and GHSA requirements.
 • Providing technical assistance in preparation for and receiving ISO 15189 
accreditation.
 • Developing a comprehensive laboratory quality assurance program and 
national testing strategy. 
One Health 
CDC works with Georgia and other partners to approach disease from a One 
Health perspective, recognizing that the health of people is connected to the 
health of animals and the environment. A coalition of partners designed and 
implemented research and surveillance in Georgia using a One Health approach, 
focusing on a previously unknown orthopoxvirus, Akhmeta virus, discovered in 
2013. CDC continues to collaborate with partners at CDC and the National Food 
Agency to collect data on the epidemiology and characteristics of the virus while 
building laboratory capacity to detect infections in humans and animals. Over 700 
animal samples have been taken and studies are being conducted to establish 
the burden of disease and identify possible risk factors for human and livestock 
infections. 
Antimicrobial Resistance
Antimicrobial resistance (AMR) and healthcare associated infections (HAI) have 
significantly affected healthcare quality worldwide, leading to higher morbidity 
and mortality, and longer hospitalizations. The Government of Georgia has 
committed to establishing the nationwide HAI/AMR Surveillance Systems by 
adopting the 2017-2020 National Strategy for Combating Antimicrobial Resistance. 
CDC AMR/HAI project activities to support the implementation of the strategy 
include:
 • HAI surveillance at selected Georgian hospitals introducing HAI protocol and 
database management skills.  
 • Training a cohort of healthcare workers on infection and prevention control 
(IPC) best practices, creating a cadre of highly qualified national trainers.   
 • Developing the new National IPC Guidelines along with 15 Georgian experts. 
 • Establishing the Richard Lugar Public Health Research Center in Tbilisi as a 
proficiency test provider.
 • Determining levels of AMR in healthcare facilities and guiding empiric therapy.
Hepatitis C 
In 2015, Georgia embarked on the world’s first national viral hepatitis elimination 
program. CDC supported population-based hepatitis C virus (HCV) serosurvey 
to determine disease burden; at the time, over 7% of adults had evidence of 
HCV infection, and over 5% were living with HCV—about 150,000 persons. CDC 
continues to support hepatitis C elimination efforts in Georgia by providing 
technical assistance to the program. 
Vaccine-Preventable Diseases
CDC has been working with the World Health Organization (WHO) and Georgian 
institutions on immunization since the 1990s, when help was provided to 
investigate the large-scale diphtheria outbreak in Georgia and an effective 
immunization campaign was implemented to control the outbreak. CDC 
continues to help Georgia achieve measles and rubella elimination by providing 
technical assistance with the analysis of epidemiologic data, surveillance reviews, 
immunization program reviews, and supplementary immunization activities. CDC 
also continues to work on ensuring Georgia remains polio-free. 
CDC IMPACT IN GEORGIA
As of 2018, 130 public health specialists 
have graduated from the CDC-supported 
South Caucasus Field Epidemiology and 
Laboratory Training (FELTP) program. 
A 3-month frontline FELTP training 
program, focused on helping regional 
and district epidemiologists from Georgia 
build surveillance and outbreak response 
skills, was established in 2018.
As of March 2019, with support from CDC, 
more than 1.5 million Georgians have 
been screened for hepatitis C virus (HCV), 
and more than 54,000 have initiated HCV 
treatment, of which 93% have completed 
treatment. 
Developed in collaboration with CDC, the 
European Association for Study of Liver 
launched the first Center of Excellence in 
Viral Hepatitis Elimination in Georgia in 
2019.
With CDC support, Georgia is the first 
country to implement a Laboratory 
Information Management System  to 
rapidly identify and contain outbreaks 
and public health emergencies. 
CDC is providing support for the 
implementation of Georgia’s National 
Strategy for Combating Antimicrobial 
Resistance. 
For more country information, visit: 
www.cdc.gov/globalhealth/countries/georgia
